Acadian Asset Management
ENZN

Acadian Asset Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Acadian Asset Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-122,287
Closed -$50K – 1670
2016
Q2 		$50K Buy
122,287
+8,847
+8% +$4.38K ﹤0.01% 1097
2016
Q1 		$54K Buy
113,440
+4,368
+4% +$2.13K ﹤0.01% 1084
2015
Q4 		$75K Sell
109,072
-8,910
-8% -$7.07K ﹤0.01% 1101
2015
Q3 		$115K Sell
117,982
-17,046
-13% -$21K ﹤0.01% 973
2015
Q2 		$161K Hold
135,028
– – ﹤0.01% 962
2015
Q1 		$145K Buy
135,028
+12,901
+11% +$13.3K ﹤0.01% 972
2014
Q4 		$133K Hold
122,127
– – ﹤0.01% 955
2014
Q3 		$132K Sell
122,127
-7,925
-6% -$9.78K ﹤0.01% 807
2014
Q2 		$135K Hold
130,052
– – ﹤0.01% 839
2014
Q1 		$134K Hold
130,052
– – ﹤0.01% 820
2013
Q4 		$151K Sell
130,052
-35,942
-22% -$55.4K ﹤0.01% 834
2013
Q3 		$279K Buy
165,994
+17,046
+11% +$31.5K ﹤0.01% 716
2013
Q2 		$298K Buy
+148,948
New +$436K ﹤0.01% 657

Other funds holding ENZN

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Acadian Asset Management's ENZN Position: Q3 2016 in Review

Acadian Asset Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 122,287 shares — an estimated $50K sold.

Acadian Asset Management first reported a position in ENZN in Q2 2013 and held it in 13 quarters. The position peaked at $298K in Q2 2013. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

  • Acadian Asset Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
  • Acadian Asset Management sold 122,287 ENZON PHARMACEUTICALS INC shares in Q3 2016, an estimated $50K.
  • Acadian Asset Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 13 quarters.
  • Acadian Asset Management's ENZON PHARMACEUTICALS INC position peaked at $298K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on Acadian Asset Management's 13F filing for Q3 2016, filed 20 Oct 2016.